A client with opioid use disorder is transitioning from meth…

A client with opioid use disorder is transitioning from methadone to buprenorphine therapy. Considering buprenorphine’s partial agonist activity at mu-opioid receptors and its pharmacodynamic properties, what is the most critical nursing consideration during this transition?